INVESTMENT OPPORTUNITY
The Future is within Our Grasp
2 1 . 1 2 . 2 0
Gra
sp A
S |
web
: gra
sp.g
lob
al
D E A L T E R M S
• Total Round Size : NOK 2.500.000
• Minimum Investment : NOK 100.000 per investor
• Pre-Money Valuation: NOK 21.000.000*
• Target: Primary existing investors and partners
• Runway: Q3 2021
* Pre-money last round 17.500.000 + equity raised last round 3.500.000 = post-money 21.000.000
Executive summary and Grasp strategy
Problem and solution
Business model and financials
Marketing, sales and competitions
Team
Target market and opportunities
Investment and use of funds
O V E R V I E W C O N T E N T
Problem Solution Market TeamOne in four experience mental health
problems during their lifetime and many experience pain and discomfort in
connection with both lifestyle diseases and health problems.
A common challenge for most people is understanding and communication about
their own condition. Today, forms, notebooks, or complicated computer tools are offered to map out how you feel. For many, this becomes too difficult. Without sufficient knowledge of how the user or
patient is doing, it is difficult to help.
Grasp you emotions – a diary without words.
With Grasp's advanced technology and simple functional design, anyone can
register experiences through squeezing. Grasp remembers when you squeezed, how
hard and for how long - as an imprint of what you experienced.
By loading data into the app and into the visualization tool, you get a complete
overview of all data. Then you can take a closer look at and analyze a specific episode,
a period and compare periods to look for trends and tendencies.
Grasp is trying to solve a global problem around communication of emotions.
B2B Somatic in Norway, with Clinics will be the primary Target Market for 2021. The company is also working on pilots in UK,
Nordics and Africa to identify product market- fit beyond Norway.
The company is planning to enter the B2C marked in 3rd quarter 2022, which is
expected to significantly increase sales.
Grasp has a highly competent team of inventors, scientists, developers, health
workers and experienced business people.
We also have several public and private partners. In 2021 we want to
strengthen in sales and market, carry out more research projects and further develop the concept in close dialogue
with our customers
Powered byGRASP AS
Current
Previous
E X E C U T I V E S U M M A R Y
W H O W E A R E
2012 (de facto), 2017 (de jure)
Bergen, Norway
Private
MedTech, HealthTech
A diary without words. Grasp your emotions. Communication re-imagened. Making subjective medical history objective. The Future is within Our Grasp
Ingvald Grindheim (CEO), Jørund Fjøsne (CSMO), Tormod Gjerde Opdal (CPO),Tor Gjøsæter (CRO), Aleksander Krzywinski (COO), Per Øystein Opdal (CMO)
www.grasp.global
Healthcare equipment - digital diagnostic and monitoring medical device(s)
Founded
Headquarters
Type
Industry
Statements
Key people
Website
Products
GRASP AS, a digital healthcare company, focuses on development, production and distribution of digital diagnostic andmonitoring medical device that facilitates communication of medical history between patients and clinicians, and enablespersonalized treatment. It operates in the major Scandinavian countries and Western Europe.
Grasp will help people globaly to communicate their emotions in a way no one ever have seen
OURVISION
STRATEGY - PURPOSE
Vision
Grasp will help people communicate what they feel. And be a natural part of treatment, both for patient and therapist
Mission
Goal
To provide healthcare market with reliable digital solutions, enhance accuracy and effectiveness of medical treatment, and enable best patient experienceTo “Grasp” will be a known and
common way to register and communicate your feelings
G R A S P - A D I A R Y W I T H O U T W O R D S
«Humans find it cognitively challenging to recodean experience into either numerical, visual,
analogue or verbal label modes.
This is especially true for children and non-native speakers. There is plenty og evidence for cultural
differences in understanding and reporting ofexperiences including both over-reporting and
under-reporting.»
Ewa G TruchanowiczBusiness Development Director
Dignio Ltd.
Cognitive challenge to recode an experience
Asymmetric communication leads to different interpretation
Limited ability or willingness to memorize events and express verbally
Experience Time Recap experience Communicate experience
C U R R E N T S I T UAT I O N – P R O B L E M I N D E TA I L
TOO
LS
Diary DiaryApps
Forms FormsForms
1.Patient receives pain form from the doctor
2.Patient experiences pain throughout the day
3.Patient subsequently fills out pain form, having to remember details
4.Discussing the pain form, which may be lacking vital data
C U R R E N T S I T UAT I O N – P R O B L E M I N D E TA I L
TOO
LS
G R A S P – S O LV I N G T H E P R O B L E M
1.Patient recieves Grasp from the doctor and agree when to use it
2.Patient register symptoms directly in real-time using Grasp and monitors their data visually with Grasp Insight App
3.Discussing data using Grasp Insight for desktop
G R A S P – A N E W D I M E N S I O N TO PAT I E N T C O M M U N I C AT I O N
EventThe patient and doctor discusses a single event that lasted for longer than normal. What happened during this event?
PeriodHere they are reading the logs for a single day, where the patient has experienced issues in a period of approx. three hours.
A period consists of multiple events within a close timeframe.
TendenciesUsing a weekly view, they can see that the patient tend to register issues several days in a row at approximately the same period every day.
- Whether you are young or old, Grasp will help you communicate your emotions easily and in a way
no one has seen before.
G R A S P – C O M M U N I C AT I O N R E - I M A G E N E D
PAIN ADDICTION
|
DEPRESSION PANIC AND ANXIETY
SOMATICS
MENTAL HEALTH
PAT I E N T G R O U P S TA R G E T M A R K E T
Geografy/Sector
Providers2021 Q1-Q2 2021 Q3-Q4 2022 Q1-Q2 2022 Q3-Q4 2023
Somatics Mental Health Somatics Mental Health Somatics Mental Health Somatics Mental Health Somatics Mental Health
B2B
NORWAY
PublicSpesialisthelsetjenesten
-Pilot BT transfer-Pilot palliative
Forhelse projectPilot rehabSales pain
Anxiety Method
developmentAddiction
Refund Helfo
Method development
Refund Helfo
PrimærhelsetjenestenSingel case study
Research painSingel case study Research pain
Method development
Refund Helfo
Method development
Refund Helfo
Private
Organizations Pilot pain 2020Sales
KreftforeningSales
Org. painSales
MH org.Sales multiple organizations
GPs Pain Study GPs Pain Study GPsMethod
developmentRefund Helfo
Method development
Refund Helfo
Healthcare providers Research painResearch pain
Sales painResearch MH Sales MH
ABROAD
NORTH AFRICA
Clinical Pain studySales private
healthcare prvSales public healthcare
UKAspergillosis Trust
studyPilot private
clinicsSales private
healthcare prvSales public healthcare
NORDICDanderyd Hospital
OTHERS FDA
B2C
NORDICEarly adopter
campaignSales B2C
AFRICA Piloting Sales B2C
EUROPE Piloting Sales B2C
US Piloting
TA R G E T M A R K E T E N T R Y S T R AT E G Y
M A R K E T P O T E N T I A L
Serviceable Obtainable Market*
Serviceable Available Market
Total Addressable Market
Total Market Potential
Estimate of 10 000 users and 200 paying customers (B2B) Somatics and Mental Health
300 000 patients in Norway undergoing healthcare treatment in Somatics and Mental Health
Global smart diagnostic and monitoring medical device market
All patients undergoing medium-/long-term healthcare treatment where clinicians need to analyze patients’ medical history – in this region:
*Limited by the production, sales and financial capacity of the company (reasonable to capture within two years)
Criteria for selecting SAM:
• Highest need - value creation
• Highest willingness to accept the product
• Marketing reach• Lowest competition and
risks• Area where company has
highest expertise• Partners’ networks
|
«Etter utallige møter forå diskutere innovasjoninnen psykisk helse, erGrasp det første prosjektetmed virkelig høg grad avnyskaping»
Dr. Paul MøllerVestre Viken
«For oss representerer Graspen liten revolusjon innene-helse»
Laila HagenDignio AS
«Ved å bruke GRASP kan man lett kartlegge og registrere symptomene og få en kvalitetssikret tilbakemelding som muliggjør raskere og bedre persontilpasset oppfølging»
Dr. Jens EspelandKommuneoverlege Sarpsborg kommune
«At last, real-time mentalhealth vital signsmonitoring»
Dr. John ShortBirmingham MentalHealth Trust
G R A S P VA LU E Q U OT E S
BASIS
+
Single user
Powered byGRASP AS
Current
Previous
PREMIUM
+
Single user + share
Kr 990 + 399/month
Powered byGRASP AS
Current
Previous +
ENTERPRISE
+
Kr 4.990/month/deptEnterprise Insight portal & admin
Kr 599/monthGrasp + Single user + share
Kr 990 + 299/month
P R I C I N G M O D E L S – F O C U S E D O N S U B S C R I P T I O N R E V E N U E S
B U S I N E S S M O D E L A T A G L A N C E
Human resources, patents, R&D, software, hardware,
production, operations
Powered byGRASP AS
Current
Previous
Digital diagnostic and monitoring medical device
VALUE CREATION
End user (patient)
Paying customer
Public and private clinicians/healthcare
Undergoing treatment most suitable for
product application
ONLINE
ORDERING
PORTAL
DIRECT SALES TEAM
VALUE DELIVERY
Physical device: 990 kr
BASIS: 299 kr
Recurring revenue model
PREMIUM App: 399 kr
ENTERPRISE: 4.990kr
VALUE CAPTUREFOR
TOFROM
Doctor / Therapist
Public and private clinicians/healthcare service
providers (B2B)
M A R K E T I N G A N D S A L E S P R O C E S S
LAUNCHPRE-LAUNCH POST-LAUNCH
ENGAGEMENT
• Website, Chat and Blog• Conferences and fairs
LOYALTY
• Website and Blog• Annual events• Community building
SERVICE
• Key account managers• Application management center• Chat, Phone and Email
PURCHASE
• Paying customer• Direct sales team and distributors• Online ordering portal • Phone and Email
C o m b i n i n g p r o d u c t l a u n c h f l o w w i t h c u s t o m e r j o u r n e y l a y e r s
+ STRATEGIC PARTNERSHIPS
AWARENESS
• References and WoM from product testing• Promoting concern through media and PR• Conferences and fairs
Grasp AS | web: grasp.global
M A N A G E M E N T T E A M
Tor Gjøsæter
CEO Research & Developement
Tormod Gjerde Opdal
Sales & Market
Ingvald Grindheim
Einar Austlid
Customer success
Alexander Krzywinski
Integrations, architecture
Jørund Fjøsne
Inventor, designer
Per Øystein Opdal
Medical officer
Eunice Hammond
Sales rep. Africa
G R A S P A D V I S O R Y B O A R D
Highly dedicated individuals with unique expertise in their field will advise Grasp.
Pål Vegard Hagen Ingvild LyhmannElin Grigoryan
Frode Guribye Lars Henrik Østevold
Psykologspesialist, privatMaster i Familieterapi og systemisk praksis
Sjøkrigsskolen og Handelshøyskolen
CEO – Daglig leder Blatchford
Professor. Institutt for informasjons- og medievitenskap,
UiB
PsykologPhD-stipendiat Kompetansesenter Helse
Bergen
P R O D U C T – A P P R O VA L S A N D PAT E N T S - I P R
Patent
Product: Pending application
.
Grasp AS | web: grasp.global
IPR Strategy
Medical Device Approval of software (app.) in 2021
QMS according to ISO in 2021
Always checking for other possible approvals needed
CE-marked and Medical Device Approved 25.02.2020
Design: Approved
Trademark and design, EU: Approved
Trademark: Approved
Unit sales
Revenues vs Cost Valuation
0
500
1 000
1 500
2 000
2 500
3 000
3 500
Q1-21 Q2-21 Q3-21 Q4-21 Q1-22 Q2-22 Q3-22 Q4-22 Q1-23 Q2-23 Q3-23 Q4-23 Q1-24 Q2-24 Q3-24 Q4-24
Annual Recurring Revenues
0
5 000 000
10 000 000
15 000 000
20 000 000
25 000 000
30 000 000
35 000 000
Q1-21 Q2-21 Q3-21 Q4-21 Q1-22 Q2-22 Q3-22 Q4-22 Q1-23 Q2-23 Q3-23 Q4-23 Q1-24 Q2-24 Q3-24 Q4-24
0
5 000 000
10 000 000
15 000 000
20 000 000
25 000 000
30 000 000
Q1-21 Q2-21 Q3-21 Q4-21 Q1-22 Q2-22 Q3-22 Q4-22 Q1-23 Q2-23 Q3-23 Q4-23 Q1-24 Q2-24 Q3-24 Q4-24
#21 Mnok
F I N A N C I A L P R O J E C T I O N S
* Pre-money last round 17.500.000 + equity raised last round 3.500.000 = post-money 21.000.000
Real-time monitoringRetrospective monitoring
Analogue tools
Digital tools
C O M P E T I TO RS A N D C O M PA R AT I V E A DVA N TA G E A N A LY S I S
Diary
• Most competitors deliver retrospective monitoringsolutions
• Traditionally monitoringtools are highly analogue
• Grasp delivers a balancedreal-time solution withlow barrier for use
Grasp concept
Forms with NRS or other scales
Multiple applications for retrospective logging
2018
Prototype
2017
Grasp AS
established
2019 / 2020
Research Edition
Mid 2019
MVP
Mid 2020
Proof of
Concept
NEXT
Start 2020
CE & Medical Device
Grasp unit
End 2020
Produced
500 units
2012
Idea
Q3 2019
Production line established
2019
Innovation
Contract
Q1 2020
Pilot project
Patent Grasp
device
Grasp AS | web: grasp.global
Q4 2020
Ready for
Clinical trials
Clinical
Trials GP
Sales to Health Care private
CE & Medical DeviceSoftware
Admin
web.app.
Pilot
Clinic
Grasp 2.0
ready
Sales to pilot customers
Pilot Business model
Clinical Trials
Clinic
Sales to Health Care public
Pilot
Hospital
DE
VE
LOP
ME
NT
SA
LES
PR
OO
F O
F
CO
NC
EP
T
H I S TO R Y A N D M I L E S TO N E S 2 0 1 7 - 2 0 2 0
Research Grants Capital raise
15 MNOKOther GrantsCapital raise
2,5 MNOK
FUN
DR
AIS
ING
Q1 2021 Q2 2021 Q3 2021 Q4 2021
O V E R V I E W U P C O M I N G F E AT U R E S
Powered byGRASP AS
Current
Previous
DIRECT FEEDBACK
CALIBRATION
Admin hospitals/clinics
LIVE MONITORING WIRELESS CHARGING
TREATMENT MODULES
ONLINE
ORDERING
PORTAL
Q1 2021
Q2 2021 Q4 2021
Q3 2021 2022
2022
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Runway6 months
2020 2021 2022 2023
DealflowmNOK 0,9
Growth loan mNOK 2,0
Debt convertingmNOK 1,25
FundraisingmNOK 1,4
Loan INmNOK 2,4
FundraisingmNOK 2,5
FundraisingmNOK 20
FundraisingmNOK 15
Runway9 months
Runway12 months
Longer runway
VC or industrial owner in Q3-21
Goals
F U N D R A I S I N G 2 0 2 1 - 2 0 2 3
Value added
• Skattefunn 2020 – 0,5 MNOK
• NRS
• Pilot Health – 0,3 MNOK
• IPN
• Eurostars
U S E O F F U N D - 2 0 2 1 - OT H E R F U N D I N G
• Research and Development
• Human Resources
• Pilot studies
• Market entry Norway, Nordic, Africa
Top Related